XAIR Stock Forecast & Price Target

Beyond Air Inc. reported a substantial revenue increase to $1.8 million for the quarter ended June 30, 2025, representing a 157% growth compared to the prior year, driven by strong demand for its LungFit PH product. The company achieved a positive gross profit of $0.2 million, indicating a significant shift in its growth trajectory and financial performance. Additionally, a national group purchasing agreement with Premier, Inc. enhances the company's access to over 4,350 hospitals, potentially accelerating commercial traction and revenue growth in both developed and emerging healthcare markets.

Beyond Air Inc. faces significant challenges that contribute to a negative outlook on its stock, primarily due to marketing and regulatory uncertainties that could adversely affect revenue streams. The company's requirement for substantial additional capital amid ongoing losses raises concerns about its financial stability and ability to maintain operations, particularly if fundamental covenants are not met. Furthermore, the competitive landscape, characterized by larger players and rapid technological advancements, coupled with the inherent risks associated with its gas delivery system, poses serious threats to its market adoption and operational viability.